Zhejiang University Center for Genetic and Genomic Medicine (ZJU-CGGM)
TAZ (tafazzin)
LOVD v.3.0 Build 29 [
Current LOVD status
]
Register as submitter
|
Log in
View all genes
View TAZ gene homepage
View graphs about the TAZ gene database
Create a new gene entry
View all transcripts
View all transcripts of gene TAZ
Create a new transcript information entry
View all variants
View all variants affecting transcripts
View unique variants in gene TAZ
View all variants in gene TAZ
Full data view for gene TAZ
Create a new data submission
View active genomic custom columns
Enable more genomic custom columns
View all individuals
View all individuals with variants in gene TAZ
Create a new data submission
View active custom columns
Enable more custom columns
View all diseases
View all diseases associated with gene TAZ
Create a new disease information entry
View available phenotype columns
View all screenings
View all screenings for gene TAZ
Create a new data submission
View active custom columns
Enable more custom columns
Submit new data
Full data view for gene TAZ
The variants shown are described using the NM_000116.3 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon
: Number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = exons 3 to 7, 8i_9 = border intron 8/exon 9.
DNA change (cDNA)
: Description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup.
RNA change
: Description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: Description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Allele
: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Type
: Type of variant at DNA level; note that the variant type can also be derived from the variant description (for all levels).
All options:
Substitution
Deletion
Duplication
Insertion
Inversion
Insertion/Deletion
Translocation
Other/Complex
DNA change (genomic) (hg19)
: Description of variant at DNA level, based on the genomic DNA reference sequence (following HGVS recommendations).
g.12345678C>T
g.12345678_12345890del
g.12345678_12345890dup
Reference
: Reference to publication describing the variant, including links to OMIM (when available), PubMed or or other source, e.g. "den Dunnen ASHG2003 P2346".
DB-ID
: Database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro.
Frequency
: Frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested).
Variant remarks
: Remarks regarding the variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
ClassClinical
: ClassClinical
Template
: Template(s) used to detect the sequence variant; DNA = genomic DNA, RNA = RNA (cDNA).
All options:
DNA
RNA = RNA (cDNA)
Protein
? = unknown
Technique
: Technique(s) used to identify the sequence variant.
All options:
? = Unknown
arrayCGH = array for Comparative Genomic Hybridisation
arraySEQ = array for resequencing
arraySNP = array for SNP typing
arrayCNV = array for Copy Number Variation (SNP and CNV probes)
BESS = Base Excision Sequence Scanning
CMC = Chemical Mismatch Cleavage
CSCE = Conformation Sensitive Capillary Electrophoresis
DGGE = Denaturing-Gradient Gel-Electrophoresis
DHPLC = Denaturing High-Performance Liquid Chromatography
DOVAM = Detection Of Virtually All Mutations (SSCA variant)
ddF = dideoxy Fingerprinting
DSCA = Double-Strand DNA Conformation Analysis
EMC = Enzymatic Mismatch Cleavage
HD = HeteroDuplex analysis
MCA = high-resolution Melting Curve Analysis (hrMCA)
IHC = Immuno-Histo-Chemistry
MAPH = Multiplex Amplifiable Probe Hybridisation
MLPA = Multiplex Ligation-dependent Probe Amplification
SEQ-NG = Next-Generation Sequencing
SEQ-NG-H = Next-Generation Sequencing - Helicos
SEQ-NG-I = Next-Generation Sequencing - Illumina/Solexa
SEQ-NG-R = Next-Generation Sequencing - Roche/454
SEQ-NG-S = Next-Generation Sequencing - SOLiD
Northern = Northern blotting
PCR = Polymerase Chain Reaction
PCRdig = PCR + restriction enzyme digestion
PCRlr = PCR, long-range
PCRm = PCR, multiplex
PCRq = PCR, quantitative
PAGE = Poly-Acrylamide Gel-Electrophoresis
PTT = Protein Truncation Test
PFGE = Pulsed-Field Gel-Electrophoresis (+Southern)
RT-PCR = Reverse Transcription and PCR
SEQ = SEQuencing
SBE = Single Base Extension
SSCA = Single-Strand DNA Conformation polymorphism Analysis (SSCP)
SSCAf = SSCA, fluorescent (SSCP)
Southern = Southern blotting
TaqMan = TaqMan assay
Western = Western Blotting
Reference
: Reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, including link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346". References in the "Country:City" format indicate that the variant was submitted directly to this database by the laboratory indicated.
Remarks
: Remarks about the individual.
Gender
: Gender
Age
: Age
α-thal genotype
: α-thal genotype
β-thal genotype
: β-thal genotype
How to query this table
All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator
Column type
Example
Matches
Text
Arg
all entries containing 'Arg'
space
Text
Arg Ser
all entries containing 'Arg' and 'Ser'
|
Text
Arg|Ser
all entries containing 'Arg' or 'Ser'
!
Text
!fs
all entries not containing 'fs'
^
Text
^p.(Arg
all entries beginning with 'p.(Arg'
$
Text
Ser)$
all entries ending with 'Ser)'
=""
Text
=""
all entries with this field empty
=""
Text
="p.0"
all entries exactly matching 'p.0'
!=""
Text
!=""
all entries with this field not empty
!=""
Text
!="p.0"
all entries not exactly matching 'p.0?'
combination
Text
*|Ter !fs
all entries containing '*' or 'Ter' but not containing 'fs'
Date
2020
all entries matching the year 2020
|
Date
2020-03|2020-04
all entries matching March or April, 2020
!
Date
!2020-03
all entries not matching March, 2020
<
Date
<2020
all entries before the year 2020
<=
Date
<=2020-06
all entries in or before June, 2020
>
Date
>2020-06
all entries after June, 2020
>=
Date
>=2020-06-15
all entries on or after June 15th, 2020
combination
Date
2019|2020 <2020-03
all entries in 2019 or 2020, and before March, 2020
Numeric
23
all entries exactly matching 23
|
Numeric
23|24
all entries exactly matching 23 or 24
!
Numeric
!23
all entries not exactly matching 23
<
Numeric
<23
all entries lower than 23
<=
Numeric
<=23
all entries lower than, or equal to, 23
>
Numeric
>23
all entries higher than 23
>=
Numeric
>=23
all entries higher than, or equal to, 23
combination
Numeric
>=20 <30 !23
all entries with values from 20 to 29, but not equal to 23
Some more advanced examples:
Example
Matches
Asian
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian
all entries containing 'Asian' but not containing 'Caucasian'
Asian|African !Caucasian
all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"
all entries containing 'South Asian', but not containing 'South East Asian'
To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
76 entries on 1 page. Showing entries 1 - 76.
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
How to query
Effect
Exon
DNA change (cDNA)
RNA change
Protein
Allele
Type
DNA change (genomic) (hg19)
Reference
DB-ID
Frequency
Variant remarks
ClassClinical
Template
Technique
Disease
Reference
Remarks
Gender
Age
α-thal genotype
β-thal genotype
Panel size
Owner
./.
10
c.700_701ins?
-
-
Unknown
Insertion
-
GenBank
TAZ_00014
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
01
c.9dup
-
p.His4AlafsX130
Unknown
Duplication
-
GenBank
TAZ_00027
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
01
c.53_54del
-
p.Leu19GlyfsX114
Unknown
Deletion
-
GenBank
TAZ_00001
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
01
c.109+1G>C
-
-
Unknown
Substitution
-
GenBank
TAZ_00050
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
01
c.109+5G>A
-
-
Unknown
Substitution
-
GenBank
TAZ_00002
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.110-2A>G
-
-
Unknown
Substitution
-
GenBank
TAZ_00054
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.123del
-
p.Leu42X
Unknown
Deletion
-
GenBank
TAZ_00032
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.127A>C
-
p.Thr43Pro
Unknown
Substitution
-
GenBank
TAZ_00049
-
Female carriers are usually healthy. In our case, the patient's mother, who is the carrier of the de novo mutation, had a normal electrocardiogram while her echo-cardiography demonstrated trabeculations of the left ventricle though did not fulfill the criteria of LVNC [24]. Her total cardiac function was normal
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.140_152del
-
p.Arg47ThrfsX32
Unknown
Deletion
-
GenBank
TAZ_00055
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.140_152del
-
p.Arg47ThrfsX32
Unknown
Deletion
-
GenBank
TAZ_00038
-
the analysis of cardiolipin in fibroblasts offers a specific biochemical approach to detect this disorder
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.153C>A
-
p.Tyr51X
Unknown
Substitution
-
GenBank
TAZ_00016
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.153C>A
-
p.Tyr51X
Unknown
Substitution
-
GenBank
TAZ_00016
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.153C>G
-
p.Tyr51X
Unknown
Substitution
-
GenBank
TAZ_00017
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.153C>G
-
p.Tyr51X
Unknown
Substitution
-
GenBank
TAZ_00017
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.153C>G
-
p.Tyr51X
Unknown
Substitution
-
GenBank
TAZ_00017
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.159dup
-
p.Ile54HisfsX80
Unknown
Duplication
-
GenBank
TAZ_00041
-
LVNC, like other forms of inherited cardiomyopathy, is a genetically heterogeneous disease, associated with variable clinical symptoms and can be inherited as an autosomal or X-linked recessive disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.159dup
-
p.Ile54HisfsX80
Unknown
Duplication
-
GenBank
TAZ_00064
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.173del
-
p.Gly58AlafsX25
Unknown
Deletion
-
GenBank
TAZ_00063
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.207C>A
-
p.His69Gln
Unknown
Substitution
-
GenBank
TAZ_00018
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.207C>A
-
p.His69Gln
Unknown
Substitution
-
GenBank
TAZ_00018
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.207C>G
-
p.His69Gln
Unknown
Substitution
-
GenBank
TAZ_00019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.207C>G
-
p.His69Gln
Unknown
Substitution
-
GenBank
TAZ_00019
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
02
c.238+2T>G
-
-
Unknown
Substitution
-
GenBank
TAZ_00053
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.239-1G>A
-
-
Unknown
Substitution
-
GenBank
TAZ_00056
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.239-1G>A
-
-
Unknown
Substitution
-
GenBank
TAZ_00021
-
BTHS is caused by mutations in the tafazzin (TAZ) gene, which is located at Xq28
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.239-1G>C
-
-
Unknown
Substitution
-
GenBank
TAZ_00057
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.239_240insC
-
p.Ile81AspfsX53
Unknown
Insertion
-
GenBank
TAZ_00061
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.280C>A
-
p.Arg94Ser
Unknown
Substitution
-
GenBank
TAZ_00037
-
another patient with a missense mutation at the same position (R94C) has been previously reported (Johnston et al. 1997). These data suggest that R94S is not a common polymorphism, but a disease-causing mutation.
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.280C>T
-
p.Arg94Cys
Unknown
Substitution
-
GenBank
TAZ_00007
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.280C>T
-
p.Arg94Cys
Unknown
Substitution
-
GenBank
TAZ_00007
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.281G>A
-
p.Arg94His
Unknown
Substitution
-
GenBank
TAZ_00042
-
Characteristic cardiac pathology findings of a TAZ gene mutation are seen in a fetus at 18 weeks
-
-
-
-
-
-
-
-
-
-
-
-
./.
03
c.284+110G>A
-
-
Unknown
Substitution
-
GenBank
TAZ_00034
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
04
c.352T>C
-
p.Cys118Arg
Unknown
Substitution
-
GenBank
TAZ_00030
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
04
c.352T>C
-
p.Cys118Arg
Unknown
Substitution
-
GenBank
TAZ_00030
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
04
c.367C>T
-
p.Arg123X
Unknown
Substitution
-
GenBank
TAZ_00044
-
BTHS is caused by mutations in the tafazzin (TAZ) gene, which is located at Xq28
-
-
-
-
-
-
-
-
-
-
-
-
./.
05
c.371-2A>G
-
-
Unknown
Substitution
-
GenBank
TAZ_00059
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
06
c.532T>A
-
p.Phe178Ile
Unknown
Substitution
-
GenBank
TAZ_00022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
06
c.532T>A
-
p.Phe178Ile
Unknown
Substitution
-
GenBank
TAZ_00022
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
06
c.535del
-
p.Pro179GlnfsX5
Unknown
Deletion
-
GenBank
TAZ_00039
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
06
c.541+1G>A
-
-
Unknown
Substitution
-
GenBank
TAZ_00046
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
07
c.548T>G
-
p.Val183Gly
Unknown
Substitution
-
GenBank
TAZ_00028
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
07
c.548T>G
-
p.Val183Gly
Unknown
Substitution
-
GenBank
TAZ_00028
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
07
c.562G>T
-
p.Glu188X
Unknown
Substitution
-
GenBank
TAZ_00035
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
07
c.580dup
-
p.Trp194LeufsX9
Unknown
Duplication
-
GenBank
TAZ_00065
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
07
c.580dup
-
p.Trp194LeufsX9
Unknown
Duplication
-
GenBank
TAZ_00043
-
BTHS is caused by mutations in the tafazzin (TAZ) gene, which is located at Xq28
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.589G>A
-
p.Gly197Arg
Unknown
Substitution
-
GenBank
TAZ_00009
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.589G>A
-
p.Gly197Arg
Unknown
Substitution
-
GenBank
TAZ_00009
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.589G>A
-
p.Gly197Arg
Unknown
Substitution
-
GenBank
TAZ_00009
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.589G>A
-
p.Gly197Arg
Unknown
Substitution
-
GenBank
TAZ_00009
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.589G>A
-
p.Gly197Arg
Unknown
Substitution
-
GenBank
TAZ_00009
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.589G>A
-
p.Gly197Arg
Unknown
Substitution
-
GenBank
TAZ_00009
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.590G>A
-
p.Gly197Glu
Unknown
Substitution
-
GenBank
TAZ_00008
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.590G>A
-
p.Gly197Glu
Unknown
Substitution
-
GenBank
TAZ_00008
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.590G>T
-
p.Gly197Val
Unknown
Substitution
-
GenBank
TAZ_00060
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.604_605insT
-
p.Glu202ValfsX18
Unknown
Insertion
-
GenBank
TAZ_00048
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.625_626delATinsGA
-
p.Ile209Asp
Unknown
Insertion/Deletion
-
GenBank
TAZ_00062
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.625_626delATinsGA
-
p.Ile209Asp
Unknown
Insertion/Deletion
-
GenBank
TAZ_00062
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.629T>G
-
p.Leu210Arg
Unknown
Substitution
-
GenBank
TAZ_00029
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.629T>G
-
p.Leu210Arg
Unknown
Substitution
-
GenBank
TAZ_00029
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.634del
-
p.Leu212CysfsX6
Unknown
Deletion
-
GenBank
TAZ_00058
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.634del
-
p.Leu212CysfsX6
Unknown
Deletion
-
GenBank
TAZ_00066
-
BTHS is caused by mutations in the tafazzin (TAZ) gene, which is located at Xq28
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.635T>C
-
p.Leu212Pro
Unknown
Substitution
-
GenBank
TAZ_00011
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.635T>C
-
p.Leu212Pro
Unknown
Substitution
-
GenBank
TAZ_00011
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.646G>A
-
p.Gly216Arg
Unknown
Substitution
-
GenBank
TAZ_00025
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
08
c.646G>A
-
p.Gly216Arg
Unknown
Substitution
-
GenBank
TAZ_00025
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
09
c.647-1G>C
-
-
Unknown
Substitution
-
GenBank
TAZ_00040
-
LVNC, like other forms of inherited cardiomyopathy, is a genetically heterogeneous disease, associated with variable clinical symptoms and can be inherited as an autosomal or X-linked recessive disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
09
c.647-1G>C
-
-
Unknown
Substitution
-
GenBank
TAZ_00051
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
09
c.684del
-
p.Arg230AlafsX9
Unknown
Deletion
-
GenBank
TAZ_00012
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
09
c.697C>T
-
p.Gln233X
Unknown
Substitution
-
GenBank
TAZ_00013
-
The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.
-
-
-
-
-
-
-
-
-
-
-
-
./.
09
c.697C>T
-
p.Gln233X
Unknown
Substitution
-
GenBank
TAZ_00013
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
10
c.700-2A>C
-
-
Unknown
Substitution
-
GenBank
TAZ_00045
-
BTHS is caused by mutations in the tafazzin (TAZ) gene, which is located at Xq28
-
-
-
-
-
-
-
-
-
-
-
-
./.
10
c.718G>A
-
p.Gly240Arg
Unknown
Substitution
-
GenBank
TAZ_00036
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
10
c.718G>A
-
p.Gly240Arg
Unknown
Substitution
-
GenBank
TAZ_00036
-
We suggest that males presenting with cardiomyopathy, particularly during infancy, even in the absence of the typical signs of Barth syndrome, should be evaluated for mutations in G4.5.
-
-
-
-
-
-
-
-
-
-
-
-
./.
10
c.718G>C
-
p.Gly240Arg
Unknown
Substitution
-
GenBank
TAZ_00026
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
10
c.777+2T>A
-
-
Unknown
Substitution
-
GenBank
TAZ_00031
-
-
-
-
-
-
-
-
-
-
-
-
-
-
./.
11
c.868_872dupCCTGG
-
p.Arg292LeufsX49
Unknown
Duplication
-
GenBank
TAZ_00047
-
We report multiple transmissions of Barth syndrome through a single oocyte donor with a de novo TAZ mutation.
-
-
-
-
-
-
-
-
-
-
-
-
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
How to query
Powered by
LOVD v.3.0
Build 29
LOVD software ©2004-2023
Leiden University Medical Center